BusinessVoyager Therapeutics Announces Additional Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s DiseaseBy Nasdaq OMXApr 25, 2017, 11:02 AM UTC
BusinessVoyager Therapeutics Licenses Novel Gene Therapy Capsids from the California Institute of TechnologyBy Nasdaq OMXSep 15, 2016, 11:05 AM UTC
